RecruitingNCT05899439
Immune Function and the Progression to T1D
Immune Function and the Progression to Type 1 Diabetes:
Sponsor
University of Florida
Enrollment
2,800 participants
Start Date
Jan 1, 2005
Study Type
OBSERVATIONAL
Conditions
Summary
To elucidate the mechanisms by which type 1 diabetes-associated genes; IFIH1, TYK2, IKZF4, as well as total genetic risk, impart functional immunoregulatory abnormalities that result in expansion of self-reactive adaptive immune cells, defective regulatory/effector mechanisms in T cells, inflammatory antigen presenting cells, and abnormal immune function in T cells and B cells.
Eligibility
Min Age: 0 YearsMax Age: 100 Years
Exclusion Criteria1
- \-
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERblood draw
a peripheral blood draw
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05899439
Related Trials
French Prospective Multicentric Study in Real World
NCT0703994224 locations
Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes
NCT059087081 location
Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
NCT0643515617 locations
A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)
NCT070396171 location
Long-Term Outcomes of Teplizumab in Routine Clinical Care
NCT073600801 location